VITASPRING BIOMEDICAL CO., LTD. Cash and Cash Equivalents, Fair Value Disclosure
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Cash and Cash Equivalents, Fair Value Disclosure of $45.40 thousand as of 2021-01-31, per its 10-K filed 2021-04-14.
Discontinued › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2021-04-14
- 2021-01-31: Cash and Cash Equivalents, Fair Value Disclosure $45.40K.
- 2020-10-31: Cash and Cash Equivalents, Fair Value Disclosure $728.00.
- 2020-07-31: Cash and Cash Equivalents, Fair Value Disclosure $728.00.
- 2020-04-30: Cash and Cash Equivalents, Fair Value Disclosure $893.00.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2021-01-31 | $45.40K 10-K · filed 2021-04-14 |
| 2020-10-31 | $728.00 10-Q · filed 2020-12-15 |
| 2020-07-31 | $728.00 10-Q · filed 2020-09-28 |
| 2020-04-30 | $893.00 10-Q · filed 2020-06-19 |
| 2020-01-31 | $0.00 10-K · filed 2021-04-14 |
| 2019-04-30 | $1.62K 10-Q · filed 2019-06-03 |